EFFECTIVE DOSE IN PEDIATRIC INTERVENTIONAL CARDIOLOGY

S S Sarycheva1

  • 1Radiation Protection Laboratory, Saint-Petersburg Research Institute of Radiation Hygiene, Saint Petersburg, Mira st. 8, 197101 St.Petersburg, Russian Federation, Russia.

Insights

This study estimated effective doses (EDs) for pediatric interventional cardiology exams. Dose conversion coefficients (DCCs) varied significantly with patient age, with newborns receiving the highest doses.

Area of Science:

  • Medical Physics
  • Pediatric Radiology
  • Radiation Dosimetry

Background:

  • Pediatric interventional cardiology procedures involve ionizing radiation.
  • Accurate estimation of effective doses (EDs) and dose conversion coefficients (DCCs) is crucial for pediatric radiation protection.
  • Variability in patient parameters and procedure techniques can influence radiation doses.

Purpose of the Study:

  • To estimate effective doses (EDs) for children undergoing interventional cardiology examinations in St. Petersburg.
  • To calculate associated dose conversion coefficients (DCCs).
  • To investigate the dependence of DCCs on patient age and examination parameters.

Main Methods:

  • Data collection from over 300 pediatric interventional cardiology examinations across three hospitals.
  • Categorization of patients into five age groups: newborn, 1, 5, 10, and 15 years old.
  • Calculation of EDs and DCCs using PCXMC 2.0 software based on collected technical, geometrical, dosimetric, and patient parameters.

Main Results:

  • Significant dependence of DCCs on patient age and beam quality was observed.
  • DCCs varied by a factor of 10 between the newborn and 15-year-old groups.
  • The maximum estimated effective dose was 26 mSv, found in the newborn age group.

Conclusions:

  • Patient age is a critical factor influencing radiation dose conversion coefficients in pediatric interventional cardiology.
  • Radiation protection strategies should account for age-specific dose variations.
  • Further research into optimizing pediatric interventional cardiology procedures to minimize radiation exposure is warranted.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
80
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
70
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
96
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
77
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
76
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
72